|
| 1 |
Can the presence of KRAS mutations guide the type of liver resection during simultaneous resection of colorectal liver metastasis?
Munseok Choi, Dai Hoon Han, Jin Sub Choi, Gi Hong Choi
|
|
| 2 |
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non–Small Cell Lung Cancer
Shinkyo Yoon, Hannah Yang, Hyun-Min Ryu, Eunjin Lee, Yujin Jo, Seyoung Seo, Deokhoon Kim, Chang Hoon Lee, Wanlim Kim, Kyung Hae Jung, Sook Ryun Park, Eun Kyung Choi, Sang-We Kim, Kang-Seo Park, Dae Ho Lee
Cancer Res Treat.2022;54(3):767-781. Published online 2021 September 30
DOI: http://dx.doi.org/10.4143/crt.2021.651
|
|
| 3 |
KRAS, NRAS, and BRAF mutations in plasma cell myeloma at a single Korean institute
Yonggoo Kim, Sung-Soo Park, Chang-Ki Min, Gun Dong Lee, Jungok Son, Sung Jin Jo, Eunhee Han, Kyungja Han, Myungshin Kim
Blood Res.2020;55(3):159-168. Published online 2020 September 30
DOI: http://dx.doi.org/10.5045/br.2020.2020137
|
|
| 4 |
Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations
Aiko Ogasawara, Taro Hihara, Daisuke Shintani, Akira Yabuno, Yuji Ikeda, Kenji Tai, Keiichi Fujiwara, Keisuke Watanabe, Kosei Hasegawa
Cancer Res Treat.2020;52(4):1219-1228. Published online 2020 May 6
DOI: http://dx.doi.org/10.4143/crt.2019.688
|
|
| 5 |
Gene variant profiles and tumor metabolic activity as measured by FOXM1 expression and glucose uptake in lung adenocarcinoma
Ashley Goodman, Waqas Mahmud, Lela Buckingham
|
|
| 6 |
Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer
Ji Eun Oh, Min Ju Kim, Joohyung Lee, Bo Yun Hur, Bun Kim, Dae Yong Kim, Ji Yeon Baek, Hee Jin Chang, Sung Chan Park, Jae Hwan Oh, Sun Ah Cho, Dae Kyung Sohn
|
|
| 7 |
Topographic, histological and molecular study of aberrant crypt foci identified in human colon in different clinical groups
Shouriyo Ghosh, Brijnandan Gupta, Pavan Verma, Sreenivas Vishnubathla, Sujoy Pal, Nihar R Dash, Siddhartha Datta Gupta, Prasenjit Das
Intest Res.2018;16(1):116-125. Published online 2018 January 18
DOI: http://dx.doi.org/10.5217/ir.2018.16.1.116
|
|
| 8 |
Mutational analysis of KRAS and its clinical implications in cervical cancer patients
Wei Jiang, Libing Xiang, Xuan Pei, Tiancong He, Xuxia Shen, Xiaohua Wu, Huijuan Yang
|
|
| 9 |
Evaluation of KRAS let-7 lcs6 Polymorphism in Korean Populations by Pyrosequencing
Jae Ho Lee, Dae Kwang Kim
|
|
| 10 |
KRAS Mutation Test in Korean Patients with Colorectal Carcinomas: A Methodological Comparison between Sanger Sequencing and a Real-Time PCR-Based Assay
Sung Hak Lee, Arthur Minwoo Chung, Ahwon Lee, Woo Jin Oh, Yeong Jin Choi, Youn-Soo Lee, Eun Sun Jung
|
|
| 11 |
Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
Seung Eun Lee, So-Young Lee, Hyung-Kyu Park, Seo-Young Oh, Hee-Joung Kim, Kye-Young Lee, Wan-Seop Kim
|
|
| 12 |
Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
Taebum Lee, Boram Lee, Yoon-La Choi, Joungho Han, Myung-Ju Ahn, Sang-Won Um
|
|
| 13 |
p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
Se Hyun Kim, Kyu Hyun Park, Sang Joon Shin, Kang Young Lee, Tae Il Kim, Nam Kyu Kim, Sun Young Rha, Jae Kyung Roh, Joong Bae Ahn
Cancer Res Treat.2016;48(1):208-215. Published online 2015 April 24
DOI: http://dx.doi.org/10.4143/crt.2014.314
|
|
| 14 |
Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?
Seung Tae Kim, Won Jin Chang, Lihua Jin, Jae Sook Sung, Yun Ji Choi, Yeul Hong Kim
Cancer Res Treat.2015;47(4):796-803. Published online 2015 January 30
DOI: http://dx.doi.org/10.4143/crt.2014.106
|
|
| 15 |
Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?
Seung Tae Kim, Kyong Hwa Park, Sang Won Shin, Yeul Hong Kim
|
|
| 16 |
The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma
Hye Ryun Kim, Jung Ryun Ahn, Jin Gu Lee, Doo Hee Bang, Sang-Jun Ha, Yun Kyoung Hong, Sun Mi Kim, Ki Chang Nam, Sun Young Rha, Ross A. Soo, Gregory J. Riely, Joo Hang Kim, Byoung Chul Cho
|
|
| 17 |
Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy
Seung Tae Kim, Kyong Hwa Park, Jun Suk Kim, Sang Won Shin, Yeul Hong Kim
|
|
